CBS and Dravet syndrome: In the rat model of DS, there was a significant reduction in total CBS protein after treatment with AOAA [24]: as AOAA's primary pharmacological effect is the inhibition of the enzyme's activity (rather than its expression), a reduction in the expression of CBS in the rats treated with AOAA is not expected.